Assessment of the economic feasibility of gadoversetamida (OptiMARK) MRI with intravenous contrast

Abstract

Gadolinium based contrast agents are widely used in MRI in a diagnostic of variety of pathologies. The quality of contrast enhancement depends on the total dose. The aim of the study is to conduct a health economic evaluation of gadoversetamide (OptiMARK, Malickrodt Pharmaceuticals) in contrast enhanced MRI. The cost-effectiveness analysis, costminimizing analysis and sensitivity analysis and budget impact analysis were used modeling contrast enhanced MRI. In results, we can say that OptiMARK is cost-effective comparing to gadopentetic acid and gadobutrol.

Keywords

• мрт
• контрастный препарат
• фармакоэкономический анализ
• анализ эффективности затрат
• анализ минимизации затрат
• анализ влияния на бюджет